Does a Higher Society of Thoracic Surgeons Score Predict Outcomes in Transfemoral and Alternative Access Transcatheter Aortic Valve Replacement?
CONCLUSIONS: As expected, non-TF patients were at a higher risk than TF patients for procedural morbidity and death. Although no differences were observed in 30-day deaths or morbidity in different STS PROM subgroups, those undergoing non-TF TAVR at a higher STS PROM (>8%) had higher 1-year mortality. When applicable, TF TAVR remains the procedure of choice in high- or extreme-risk patients undergoing TAVR.
PMID: 27209615 [PubMed - as supplied by publisher]
Source: The Annals of Thoracic Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Jensen HA, Thourani VH, Forcillo J, Condado JF, Binongo JN, Babaliaros V, Lasanajak Y, Leshnower B, Devireddy C, Guyton R, Mavromatis K, Block P, Simone A, Keegan P, Stewart J, Tsai LL, Rajaei MH, Lerakis S, Sarin EL Tags: Ann Thorac Surg Source Type: research